Page last updated: 2024-10-22

amiodarone and Fractures, Bone

amiodarone has been researched along with Fractures, Bone in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Fractures, Bone: Breaks in bones.

Research Excerpts

ExcerptRelevanceReference
"Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture."7.74Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2007)
"Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture."3.74Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, PC1
Park-Wyllie, LY1
Juurlink, DN1
Rejnmark, L1
Vestergaard, P1
Mosekilde, L1

Other Studies

2 other studies available for amiodarone and Fractures, Bone

ArticleYear
Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs.
    Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:8

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Case-Control Studies; Cohort Studies; Diphosphonates; Epid

2014
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2007, Volume: 18, Issue:4

    Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillat

2007